Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling.


Journal

EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 06 03 2020
revised: 01 06 2020
accepted: 09 06 2020
pubmed: 7 7 2020
medline: 26 5 2021
entrez: 7 7 2020
Statut: ppublish

Résumé

Precision medicine approaches aim to tackle diseases on an individual level through molecular profiling. Despite the growing knowledge about diseases and the reported diversity of molecular phenotypes, the descriptions of human health on an individual level have been far less elaborate. To provide insights into the longitudinal protein signatures of well-being, we profiled blood plasma collected over one year from 101 clinically healthy individuals using multiplexed antibody assays. After applying an antibody validation scheme, we utilized > 700 protein profiles for in-depth analyses of the individuals' short-term health trajectories. We found signatures of circulating proteomes to be highly individual-specific. Considering technical and longitudinal variability, we observed that 49% of the protein profiles were stable over one year. We also identified eight networks of proteins in which 11-242 proteins covaried over time. For each participant, there were unique protein profiles of which some could be explained by associations to genetic variants. This observational and non-interventional study identifyed noticeable diversity among clinically healthy subjects, and facets of individual-specific signatures emerged by monitoring the variability of the circulating proteomes over time. To enable more personal hence precise assessments of health states, longitudinal profiling of circulating proteomes can provide a valuable component for precision medicine approaches. This work was supported by the Erling Persson Foundation, the Swedish Heart and Lung Foundation, the Knut and Alice Wallenberg Foundation, Science for Life Laboratory, and the Swedish Research Council.

Sections du résumé

BACKGROUND BACKGROUND
Precision medicine approaches aim to tackle diseases on an individual level through molecular profiling. Despite the growing knowledge about diseases and the reported diversity of molecular phenotypes, the descriptions of human health on an individual level have been far less elaborate.
METHODS METHODS
To provide insights into the longitudinal protein signatures of well-being, we profiled blood plasma collected over one year from 101 clinically healthy individuals using multiplexed antibody assays. After applying an antibody validation scheme, we utilized > 700 protein profiles for in-depth analyses of the individuals' short-term health trajectories.
FINDINGS RESULTS
We found signatures of circulating proteomes to be highly individual-specific. Considering technical and longitudinal variability, we observed that 49% of the protein profiles were stable over one year. We also identified eight networks of proteins in which 11-242 proteins covaried over time. For each participant, there were unique protein profiles of which some could be explained by associations to genetic variants.
INTERPRETATION CONCLUSIONS
This observational and non-interventional study identifyed noticeable diversity among clinically healthy subjects, and facets of individual-specific signatures emerged by monitoring the variability of the circulating proteomes over time. To enable more personal hence precise assessments of health states, longitudinal profiling of circulating proteomes can provide a valuable component for precision medicine approaches.
FUNDING BACKGROUND
This work was supported by the Erling Persson Foundation, the Swedish Heart and Lung Foundation, the Knut and Alice Wallenberg Foundation, Science for Life Laboratory, and the Swedish Research Council.

Identifiants

pubmed: 32629387
pii: S2352-3964(20)30229-2
doi: 10.1016/j.ebiom.2020.102854
pmc: PMC7334812
pii:
doi:

Substances chimiques

Antibodies 0
Blood Proteins 0
Proteome 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102854

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Références

PLoS Genet. 2016 Aug 17;12(8):e1006011
pubmed: 27532455
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Nature. 2018 Jun;558(7708):73-79
pubmed: 29875488
Nat Methods. 2016 Oct;13(10):823-7
pubmed: 27595404
Blood. 1998 Mar 15;91(6):2010-4
pubmed: 9490684
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
J Intern Med. 2015 Dec;278(6):645-59
pubmed: 26096600
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
J Proteome Res. 2019 Jul 5;18(7):2706-2718
pubmed: 31094526
Bioinformatics. 2008 Mar 1;24(5):719-20
pubmed: 18024473
Proteomics. 2005 Nov;5(17):4327-37
pubmed: 16237735
Cell Syst. 2018 Feb 28;6(2):157-170.e8
pubmed: 29361466
Proteomics. 2019 Aug;19(15):e1900008
pubmed: 31278833
EMBO Mol Med. 2019 Nov 7;11(11):e10427
pubmed: 31566909
Science. 2019 Dec 20;366(6472):
pubmed: 31857451
Proteomics. 2013 Dec;13(23-24):3406-10
pubmed: 24151238
Circulation. 2017 Apr 25;135(17):1651-1664
pubmed: 28438806
J Proteome Res. 2019 Dec 6;18(12):4085-4097
pubmed: 31573204
J Proteomics. 2013 Dec 16;95:46-54
pubmed: 23631827
Cell. 2016 May 5;165(4):780-91
pubmed: 27153492
Sci Signal. 2019 Nov 26;12(609):
pubmed: 31772123
Sci Rep. 2019 Jun 6;9(1):8324
pubmed: 31171813
Nat Biotechnol. 2017 Aug;35(8):747-756
pubmed: 28714965
Science. 2018 Aug 24;361(6404):769-773
pubmed: 30072576
Nature. 2009 Aug 20;460(7258):1011-5
pubmed: 19587683
Methods Mol Biol. 2013;1023:137-45
pubmed: 23765623
Nat Med. 2019 Dec;25(12):1851-1857
pubmed: 31792462
Blood Coagul Fibrinolysis. 2010 Oct;21(7):632-9
pubmed: 20814302
Am J Hum Genet. 2010 Apr 9;86(4):626-31
pubmed: 20303064
J Proteome Res. 2017 Dec 1;16(12):4299-4310
pubmed: 28938075
Nat Rev Genet. 2016 Oct;17(10):615-29
pubmed: 27498692
Clin Chem. 2016 Jan;62(1):179-87
pubmed: 26453697
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
J Thromb Thrombolysis. 2019 Oct;48(3):466-474
pubmed: 31124034
Twin Res Hum Genet. 2013 Feb;16(1):317-29
pubmed: 23137839

Auteurs

Tea Dodig-Crnković (T)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden.

Mun-Gwan Hong (MG)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden.

Cecilia Engel Thomas (CE)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden.

Ragna S Häussler (RS)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden.

Annika Bendes (A)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden.

Matilda Dale (M)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden.

Fredrik Edfors (F)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.

Björn Forsström (B)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden.

Patrik K E Magnusson (PKE)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm 171 77, Sweden.

Ina Schuppe-Koistinen (I)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Center for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 171 77, Sweden.

Jacob Odeberg (J)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT the Arctic University of Norway, Tromsø 9010, Norway; Coagulation unit, Department of Hematology, Karolinska University Hospital, Stockholm 171 76, Sweden.

Linn Fagerberg (L)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden.

Anders Gummesson (A)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg 413 45, Sweden; Region Västra Götaland, Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden.

Göran Bergström (G)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg 413 45, Sweden; Region Västra Götaland, Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden.

Mathias Uhlén (M)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden; Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby 2800, Denmark.

Jochen M Schwenk (JM)

Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Tomtebodavägen 23, Stockholm 171 65, Sweden. Electronic address: jochen.schwenk@scilifelab.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH